To evaluate whether VP18/58 treatment affects GBM cell migration in the hypoxic condition, we performed a wound-healing assay in both cell lines exposed to DFX for 24 h with or without the HO-1 inhibitor. The gene discussed is HMOX1; the disease is glioblastoma.